Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06430931 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery

Study acronym: ProTex
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jul 1, 2026 to Jul 1, 2027
    • Secondary endpoints: details revised at 13 of 13 entries
    v3
  2. Study description expanded, about 1 wordv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective study aims to assess the efficacy of the OviTex 1S permanent mesh in pelvic floor surgery in comparison with the current standard polypropylene mesh.
Trial Details
NCT Number NCT06430931
Lead Sponsor Meander Medical Center
Collaborators: Health Holland
Conditions
(from sponsor)		 Colorectal Disorders, Prolapse, Prolapse Rectal, Prolapse Genital, Prolapse Pelvic, Rectocele, Prolapse Uterus, Cystocele +3 more
Related terms Cystocele, Hernia, Prolapse, Rectal Prolapse, Rectocele, Uterine Prolapse
Enrollment 184 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov